PMC.F 118 (+0.85%)
AU000000PME8Healthcare Providers & ServicesHealth Information Services

Pro Medicus (PMC.F) Stock Highlights

118 | +0.85%
2025-04-03 21:01:46
Pro Medicus is a healthcare IT company specialising in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Statistics

Range Today
111 118
Volume Today 31
Range 1 Year
59 184
Volume 1 Year 24.25K
Range 3 Year
24.8 184
Volume 3 Year 36.49K
Range 10 Year
3.11 184
Volume 10 Year 181.27K

Highlights

Market Capitalization 14.53B (large)
Floating Shares 52.98M
Current Price 118
Price To Earnings 212.96
Price To Revenue 64.11
Price To Book 55.01
Earnings Per Share 0.54
Dividend Yield 0.24%
Dividend Per Share 0.29
Payout Ratio 42.58%

Performance

Latest +0.85%
1 Month -23.38%
3 Months -21.85%
6 Months +8.26%
1 Year +96.67%
3 Years +266.46%
5 Years +938.73%
10 Years +2762.69%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.